Your browser doesn't support javascript.
loading
Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes.
Eriksson, Olof; Velikyan, Irina; Haack, Torsten; Bossart, Martin; Laitinen, Iina; Larsen, Philip J; Berglund, Jan Erik; Antoni, Gunnar; Johansson, Lars; Pierrou, Stefan; Tillner, Joachim; Wagner, Michael.
Afiliação
  • Eriksson O; Antaros Medical AB, Uppsala, Sweden; olof.eriksson@antarosmedical.com michael.wagner@sanofi.com.
  • Velikyan I; Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
  • Haack T; Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
  • Bossart M; Akademiska Sjukhuset, Uppsala, Sweden.
  • Laitinen I; R&D Research Platform, Integrated Drug Discovery, Sanofi, Frankfurt, Germany.
  • Larsen PJ; R&D Research Platform, Integrated Drug Discovery, Sanofi, Frankfurt, Germany.
  • Berglund JE; Global Imaging, Sanofi, Frankfurt, Germany.
  • Antoni G; Diabetes Research, Sanofi, Frankfurt, Germany.
  • Johansson L; Clinical Trial Consultants AB, Uppsala, Sweden; and.
  • Pierrou S; Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
  • Tillner J; Akademiska Sjukhuset, Uppsala, Sweden.
  • Wagner M; Antaros Medical AB, Uppsala, Sweden.
J Nucl Med ; 63(5): 794-800, 2022 05.
Article em En | MEDLINE | ID: mdl-34503957

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article